Leaflet MEPHAQUIN LACTAB 250mg film-coated tablets

Product code:
W70383001
Quantity:
8
Indicated for:
malaria
Route of administration:
oral
Substance:
mefloquine (antimalarial)
ATC
P01BC02 — Antiparasitic products, insecticides and repellents | Antimalarials | Methanolquinolines
Mefloquine is a medication used for the prevention and treatment of malaria. It is effective against several Plasmodium species, including Plasmodium falciparum, which is responsible for severe forms of malaria.

This medication is taken orally, usually once a week for prophylaxis or according to a specific regimen for treatment. It is important to start taking it at least one week before traveling to an endemic area and to continue for several weeks after returning.

Mefloquine may cause side effects such as nausea, dizziness, or sleep disturbances. In rare cases, neuropsychiatric reactions such as anxiety or depression may occur. Patients with a history of psychiatric disorders should avoid using this medication.

To ensure effectiveness, it is essential to follow the dosing schedule and consult a doctor before use, especially if taking other medications.

General data about MEPHAQUIN LACTAB 250mg

Substance:
mefloquine
Date of latest medicines list:
01-06-2026
Product code:
W70383001
Concentration:
250mg
Pharmaceutical form:
film-coated tablets
Quantity:
8
Product type:
Generic medicine
Price:
392.68 RON
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
ACINO ESTONIA - ESTONIA
Holder:
TEVA PHARMACEUTICALS S.R.L. - ROMANIA
Number:
922/2024/01
Shelf life:
5 years

Pharmaceutical forms available for mefloquine

Compensation lists for MEPHAQUIN LACTAB 250mg Teva

NHP 1.A (C2) - People with HIV/AIDS and post-exposure treatment

Price
392.68 RON
Copayment
392.68 RON
Patient
0.00 RON